Cargando…

Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up

Background: Flow diverters are widely used as the first endovascular treatment option for complex brain aneurysms due to their high percentage of occlusion and low morbi-mortality. The Silk Vista device is a new generation of flow diverters designed to facilitate full visibility, improve apposition...

Descripción completa

Detalles Bibliográficos
Autores principales: Pumar, José M., Mosqueira, Antonio, Olier, Jorge, Rodriguez-Fernandez, Claudio, Vega, Pedro, Gonzalez-Diaz, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299702/
https://www.ncbi.nlm.nih.gov/pubmed/34305807
http://dx.doi.org/10.3389/fneur.2021.713389
_version_ 1783726319409823744
author Pumar, José M.
Mosqueira, Antonio
Olier, Jorge
Rodriguez-Fernandez, Claudio
Vega, Pedro
Gonzalez-Diaz, Eva
author_facet Pumar, José M.
Mosqueira, Antonio
Olier, Jorge
Rodriguez-Fernandez, Claudio
Vega, Pedro
Gonzalez-Diaz, Eva
author_sort Pumar, José M.
collection PubMed
description Background: Flow diverters are widely used as the first endovascular treatment option for complex brain aneurysms due to their high percentage of occlusion and low morbi-mortality. The Silk Vista device is a new generation of flow diverters designed to facilitate full visibility, improve apposition to the vessel wall, and enhance navigability. Indeed, its greatest advantage is that it enables the easier navigation of stents between 3.5 and 4.75 mm through a 0.021 microcatheter. The objective of this study was to evaluate the safety and effectiveness of Silk Vista systems for treating cerebral aneurysms. Methods: This prospective observational study included 25 consecutive patients with 27 wide-necked unruptured aneurysms treated with SILK Vista who were retrospectively analyzed for safety and efficacy. Results: Endovascular treatment was successfully performed in all patients. The final morbidity and mortality rates were both 0.0%. Short-term (3–5 months) angiographic follow-up revealed 21 complete occlusions and 6 near-complete occlusions. No significant parent artery stenosis was observed. Conclusions: This report demonstrates the efficacy of Silk Vista in treating brain aneurysms, although longer experiences should be carried out to confirm our results.
format Online
Article
Text
id pubmed-8299702
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82997022021-07-24 Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up Pumar, José M. Mosqueira, Antonio Olier, Jorge Rodriguez-Fernandez, Claudio Vega, Pedro Gonzalez-Diaz, Eva Front Neurol Neurology Background: Flow diverters are widely used as the first endovascular treatment option for complex brain aneurysms due to their high percentage of occlusion and low morbi-mortality. The Silk Vista device is a new generation of flow diverters designed to facilitate full visibility, improve apposition to the vessel wall, and enhance navigability. Indeed, its greatest advantage is that it enables the easier navigation of stents between 3.5 and 4.75 mm through a 0.021 microcatheter. The objective of this study was to evaluate the safety and effectiveness of Silk Vista systems for treating cerebral aneurysms. Methods: This prospective observational study included 25 consecutive patients with 27 wide-necked unruptured aneurysms treated with SILK Vista who were retrospectively analyzed for safety and efficacy. Results: Endovascular treatment was successfully performed in all patients. The final morbidity and mortality rates were both 0.0%. Short-term (3–5 months) angiographic follow-up revealed 21 complete occlusions and 6 near-complete occlusions. No significant parent artery stenosis was observed. Conclusions: This report demonstrates the efficacy of Silk Vista in treating brain aneurysms, although longer experiences should be carried out to confirm our results. Frontiers Media S.A. 2021-07-09 /pmc/articles/PMC8299702/ /pubmed/34305807 http://dx.doi.org/10.3389/fneur.2021.713389 Text en Copyright © 2021 Pumar, Mosqueira, Olier, Rodriguez-Fernandez, Vega and Gonzalez-Diaz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Pumar, José M.
Mosqueira, Antonio
Olier, Jorge
Rodriguez-Fernandez, Claudio
Vega, Pedro
Gonzalez-Diaz, Eva
Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up
title Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up
title_full Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up
title_fullStr Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up
title_full_unstemmed Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up
title_short Treatment of Intracranial Aneurysms Using the New Silk Vista Flow Diverter: Safety Outcomes at Short-Term Follow-Up
title_sort treatment of intracranial aneurysms using the new silk vista flow diverter: safety outcomes at short-term follow-up
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299702/
https://www.ncbi.nlm.nih.gov/pubmed/34305807
http://dx.doi.org/10.3389/fneur.2021.713389
work_keys_str_mv AT pumarjosem treatmentofintracranialaneurysmsusingthenewsilkvistaflowdivertersafetyoutcomesatshorttermfollowup
AT mosqueiraantonio treatmentofintracranialaneurysmsusingthenewsilkvistaflowdivertersafetyoutcomesatshorttermfollowup
AT olierjorge treatmentofintracranialaneurysmsusingthenewsilkvistaflowdivertersafetyoutcomesatshorttermfollowup
AT rodriguezfernandezclaudio treatmentofintracranialaneurysmsusingthenewsilkvistaflowdivertersafetyoutcomesatshorttermfollowup
AT vegapedro treatmentofintracranialaneurysmsusingthenewsilkvistaflowdivertersafetyoutcomesatshorttermfollowup
AT gonzalezdiazeva treatmentofintracranialaneurysmsusingthenewsilkvistaflowdivertersafetyoutcomesatshorttermfollowup